Belgium Medical Inc.: Great Success at ANMA 23rd Annual Convention, Las Vegas, July 30-August 1, 2
8/25/2004
Belgium Medical Inc.: Great Success at ANMA 23rd Annual
Convention, Las Vegas, July 30-August 1, 2004 VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Aug. 25, 2004) - Meridian Co., Ltd. ("Meridian") (OTC BB: MRDAF), is pleased to announce that its subsidiary, Belgium Medical Inc. ("MMI" or "the Company") experienced great success at the American Naturopathic Medical Association's ("ANMA") 23rd annual convention in Las Vegas. The Company was there to introduce the Digital Pulse Analyzer ("DPA") to the North American market. Using the DPA, the Company and their US Distributor, CardioGrade, tested approximately 300 participants over the weekend convention. The President of MMI, Debbie Williams stated, "The positive response to the DPA was overwhelming." "The Company's booth had unbelievable response throughout the show with everyone expressing interest in Meridian's product and technology." Meridian has taken 15 initial orders for the DPA with further orders pending. The Company felt the trade show was a great indication of the potential for this product not only in the United States but throughout North America. More about: Digital Pulse Analyzer ("DPA") The "DPA" accurately measures the elasticity of small and large arteries and provides health care practitioners with critical information regarding arterial aging. This FDA approved device is inexpensive, non-invasive, and can provide results in minutes. Accumulating evidence suggests that abnormalities in the pulsatile characteristics of arteries occur early in the disease process associated with increased cardiovascular risk, and can be favorably modified by therapeutic interventions. The Company feels that use of the "DPA" can help caregivers reduce cardiovascular disease in their patient populations through early detection and prevention, and ultimately assist to decrease the associated financial costs placed on the health care industry. Cardiovascular disease is the #1 killer in the United States with an estimated economic cost of approximately $298 billion. ABOUT MERIDIAN Meridian is an established leader in the research/development, manufacturing, and sales of integrative medical diagnostic equipment. The company sells its products and equipment to a wide array of customers in the global health care industry. The company presently holds a total of 18 worldwide patents on its technology, and has received FDA, as well as other international regulatory approvals for many of its products. Meridian is committed to the ongoing global research and advancement of integrative medical products that contribute to the better health of humanity. Website (North America): meridianmedical.ca Website (Korean): www.meridian.co.kr -30- FOR FURTHER INFORMATION PLEASE CONTACT: Lexington Communications Larry Kristof 1-877-899-4550 Email:
|